Also trades as: 0IV3.L (LSE) · $vol 0M
GERN NASDAQ
Geron Corporation
1W: -10.6%
1M: -14.0%
3M: +18.4%
YTD: +2.3%
1Y: +4.7%
3Y: -44.7%
5Y: -7.5%
$1.35
-0.02 (-1.46%)
Weekly Expected Move ±7.9%
$1
$1
$1
$1
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$866.1M
52W Range1.04-2.01
Volume5,011,803
Avg Volume12,263,375
Beta0.60
Dividend—
Analyst Ratings
Company Info
CEOHarout Semerjian
Employees258
SectorHealthcare
IndustryBiotechnology
IPO Date1996-07-31
Websitegeron.com
919 East Hillsdale Boulevard
Foster City, CA 94404
US
Foster City, CA 94404
US
650 473 7700
About Geron Corporation
Geron Corporation is an advanced-stage biopharmaceutical company dedicated to the creation and market introduction of treatments for myeloid blood cancers. Its primary drug candidate, imetelstat, is a telomerase inhibitor currently undergoing Phase 3 clinical evaluation. This therapy aims to suppress the unchecked proliferation of cancerous stem and progenitor cells characteristic of myeloid hematologic malignancies. Imetelstat is being developed to address low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. Established in 1990, Geron's corporate headquarters are located in Foster City, California.
Latest News
ADAR1 Capital Management LLC Invests $647,000 in Geron Corporation $GERN
Geron (NASDAQ:GERN) Shares Up 6.4% - Here's What Happened - MarketBeat
Geron (GERN) Is Up 15.6% After Raising 2026 RYTELO Revenue Guidance And Filing New ESOP Shares - simplywall.st
Geron Corporation $GERN Stake Raised by Renaissance Technologies LLC - MarketBeat
Geron (GERN) Stock Looks Reasonable On Sales But Weak On Returns
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Spiegel Robert J. | A-Award | 6,103 | $1.28 | 2026-06-30 |
| Spiegel Robert J. | A-Award | 220,000 | $1.26 | 2026-05-20 |
| O'Farrell Elizabeth | A-Award | 220,000 | $1.26 | 2026-05-20 |
| Molineaux Susan | A-Award | 220,000 | $1.26 | 2026-05-20 |
| McDonald John F | A-Award | 220,000 | $1.26 | 2026-05-20 |